Partnerships are an integral aspect of Aidoc’s ability to be a single, coordinated healthcare AI solution. With the vendor-neutral Aidoc aiOS™, you have the ability to run both Aidoc and third-party algorithms, integrate seamlessly into an existing IT stack and unify technology into one end-to-end platform.
Customers of select original equipment manufacturers can purchase Aidoc solutions directly through their existing partner, streamlining communication and expediting integration.
Aidoc’s 17 FDA-cleared algorithms and established strategic partnerships with other leading developers provides a suite of robust clinical solutions, all deployed seamlessly from Aidoc’s aiOS™.
Interoperability is essential to AI success. Aidoc’s aiOS™ is vendor-agnostic and connects to existing user systems, including PACS, VNA, worklists, EHR, scheduling and communication interfaces. Aidoc is the only AI vendor available within Epic‘s App Orchard, and it’s the only vendor that can integrate with Radiant to provide acuity-based feedback within radiologists’ workflow. This is not a comprehensive list of integrations. Please contact Aidoc to discuss your specific systems.
Aidoc has a vendor-neutral approach, meaning our operating system is customizable to your existing IT stack. It will run effectively in any clinical setting and can orchestrate numerous AI applications at once.
Through three unique layers of innovation – a highly accurate algorithmic layer, a robust product layer, and a clinically viable solution layer – Aidoc is built to serve as a single interface to unify an entire suite of AI solutions.
Reach out to our team here to discuss your needs. Aidoc is also available through three authorized resellers: Change Healthcare, Merative and Radiology Partners.
“These guys are changing the way radiology is practiced in leaps and bounds and they’ve cracked the code on what it takes to rapidly progress from concept to AI product development to FDA approval to deployment and workflow integration. In my view they are off and running as the lead horse in the race to corner the imaging AI market.”
